₹289.90
+1.79%NSE close, 16 Nov 2026
−6.60%
Jupiter Life Line Hospitals is a small cap company, listed on NSE under the symbol JLHL. At ₹289.90 a share, the market values the whole company at ₹9,504 crore.
In FY26, it reported sales of ₹1,500 crore and a net profit of ₹194 crore, an operating margin of 22.9%.
The market values the company at 50.9 times its profit over the last twelve months and 5.83 times its book value; its return on equity is 11.5% and its borrowings are 0.36 times its equity.
Promoters hold 40.91% of the shares. Foreign institutions hold 9.13%, and domestic institutions, mutual funds among them, 19.13%.
Over the past year the share price has fallen 6.7%, and it is 14.7% below its 52-week high.
₹ crore. Consolidated figures.
Addition of approximately 40-50 beds to the existing Thane Hospital.
Schedule of meet
Q2 FY27 Earnings Conference Call Transcript
Link of Recording
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 273 | 290 | 287 | 323 | 321 | 327 | 348 | 394 | 365 | 388 | 411 | 457 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 211 | 228 | 223 | 248 | 246 | 248 | 270 | 301 | 282 | 299 | 332 | 350 |
| Operating profit | 61.9 | 62.3 | 63.9 | 75.0 | 75.0 | 78.3 | 78.1 | 92.3 | 83.4 | 89.2 | 79.3 | 107 |
| Operating margin | 22.7% | 21.4% | 22.2% | 23.2% | 23.4% | 24.0% | 22.5% | 23.4% | 22.8% | 23.0% | 19.3% | 23.4% |
| Other income | 8.1 | 9.0 | 8.4 | 9.4 | 8.3 | 7.0 | 12.9 | 11.3 | 9.1 | 9.2 | 10.6 | 10.5 |
| Interest | 1.0 | 0.9 | 1.1 | 1.1 | 2.8 | 5.6 | 8.3 | 7.8 | 7.6 | 9.0 | 12.9 | 13.8 |
| Depreciation | 10.7 | 10.4 | 11.0 | 14.4 | 14.0 | 17.6 | 21.2 | 21.5 | 21.7 | 23.3 | 26.4 | 28.5 |
| Profit before tax | 58.1 | 62.2 | 60.1 | 68.9 | 66.6 | 62.1 | 61.5 | 74.2 | 56.9 | 66.1 | 50.6 | 75.1 |
| Tax | 14.4 | 16.9 | 15.5 | 17.4 | 14.0 | 17.2 | 17.7 | 16.8 | 14.4 | 17.3 | 13.0 | 18.7 |
| Net profit | 43.7 | 45.3 | 44.6 | 51.5 | 52.5 | 44.9 | 43.8 | 57.4 | 42.6 | 50.6 | 37.5 | 56.2 |
| EPS (₹) | 6.56 | 6.49 | 6.80 | 7.86 | 8.01 | 6.84 | 6.69 | 8.75 | 6.49 | 7.66 | 5.72 | 1.72 |
₹ crore, financial years to March.
| Line | FY24 | FY25 | FY26 |
|---|---|---|---|
| Sales | 1,070 | 1,262 | 1,500 |
| Expenses | 831 | 965 | 1,157 |
| Operating profit | 238 | 297 | 343 |
| Operating margin | 22.3% | 23.5% | 22.9% |
| Other income | 26.0 | 28.7 | 42.4 |
| Interest | 26.4 | 10.6 | 32.7 |
| Depreciation | 42.4 | 57.0 | 87.6 |
| Profit before tax | 195 | 258 | 265 |
| Tax | 18.8 | 64.2 | 66.3 |
| Net profit | 177 | 193 | 194 |
| EPS (₹) | 28.65 | 29.47 | 29.59 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|
| From operations | 253 | 268 | 136 |
| From investing | −209 | −442 | −176 |
| From financing | 301 | 136 | 28.4 |
| Spent on fixed assets | −321 | −502 | −293 |
| Free cash flow | −67.4 | −234 | −157 |
Margins, returns, debt, tax and cash.
| Line | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net margin | 16.5% | 15.3% | 13.0% |
| Operating margin | 22.3% | 23.5% | 22.9% |
| Return on equity | 15.1% | 14.2% | 12.6% |
| Return on capital employed | 19.0% | 15.9% | 14.5% |
| Return on assets | 13.8% | 10.1% | 8.2% |
| Debt to equity | 0.00 | 0.24 | 0.33 |
| Interest coverage | 8.40 | 25.40 | 9.10 |
| Debt to assets | 0.00 | 0.17 | 0.21 |
| Current ratio | 3.87 | 4.51 | 3.02 |
| Quick ratio | 3.67 | 4.35 | 2.85 |
| Cash ratio | 2.85 | 2.42 | 0.24 |
| Asset turnover | 0.83 | 0.66 | 0.63 |
| Fixed asset turnover | 1.49 | 1.30 | 1.09 |
| Inventory turnover | 8.90 | 9.60 | 7.50 |
| Receivables turnover | 18.70 | 30.10 | 19.90 |
| Gross margin | 82.3% | 81.8% | 80.8% |
| Cash from operations to profit | – | 131.0% | 138.0% |
| Effective tax rate | 9.6% | 24.9% | 25.0% |
Outcome of the Board Meeting held on Friday, October 23, 2026
Outcome of the Board Meeting held on Friday, October 23, 2026
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulation ) Execution of Hypothecation Agreement.
Schedule of meet
Intimation under Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements Regulations), 2015 ( Listing Regulation )
Appointment of Mr. Harshad Purani as Chief Financial Officer of the company w.e.f. July 31, 2026.
Outcome of Board Meeting dated July 31, 2026